Esperion Therapeutics Inc (ESPR)
Net Change in Cash
-$11.69M
Quarterly · Period ending: · USD
ESPR Net Change in Cash
Latest reported-$11.69Mperiod ending
Latest reported-$11.69Mperiod ending
ESPR Quarterly Net Change in Cash ($21.79M → -$11.69M)
Quarterly net change in cash
High-resolution chart · PNG
ESPR net change in cash history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Change in Cash (USD) |
|---|---|
| -11,694,000 | |
| 75,405,000 | |
| 6,386,000 | |
| -28,572,000 | |
| -30,128,000 | |
| 44,000 | |
| -44,587,000 | |
| -37,305,000 | |
| 144,361,000 | |
| -32,585,000 | |
| -23,637,000 | |
| -6,441,000 | |
| 20,136,000 | |
| -34,624,000 | |
| 36,459,000 | |
| -27,424,000 | |
| -58,528,000 | |
| 105,220,000 | |
| -65,514,000 | |
| 1,247,000 | |
| -87,023,000 | |
| 89,214,000 | |
| -82,741,000 | |
| 148,175,000 | |
| -16,744,000 | |
| -45,848,000 | |
| -62,366,000 | |
| 99,243,000 | |
| 139,056,000 | |
| 10,218,000 | |
| 2,375,000 | |
| -6,443,000 | |
| -3,645,000 | |
| 13,444,000 | |
| 651,000 | |
| 506,000 | |
| -18,298,000 | |
| -8,975,000 | |
| -1,628,000 | |
| 11,561,000 | |
| -40,129,000 | |
| -3,488,000 | |
| -48,963,000 | |
| -78,854,000 | |
| 123,603,000 | |
| 44,806,000 | |
| -7,712,000 | |
| -694,000 | |
| -7,899,000 | |
| -15,358,467 | |
| 55,268,969 | |
| 12,740,643 | |
| -2,625,305 | |
| 3,346,447 | |
| 1,115,395 | |
| -2,829,732 | |
| 3,308,327 | |
| 36,479,000 | |
| -3,399,000 | |
| -8,894,000 | |
| -887,000 | |
| -4,292,000 | |
| -18,245,000 | |
| -6,363,000 | |
| -6,699,000 | |
| 23,298,000 | |
| -10,974,000 | |
| -5,567,000 | |
| -5,410,000 | |
| 52,953,000 | |
| -5,013,068 | |
| 21,794,136 |